Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue
Submit an article Journal homepage
83
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study

Claus F Vogelmeier1 Member of the German Center for Lung Research (DZL), Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Marburg, GermanyCorrespondence[email protected]
,
Kenneth R Chapman2 Asthma and Airway Centre, University Health Network and University of Toronto, Toronto, ON, Canada
,
Marc Miravitlles3 Pneumology Department, Hospital Universitari Vall d’Hebron, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain
,
Nicolas Roche4 Service de Pneumologie AP-HP, Cochin Hospital, University Paris Descartes (EA2511), Paris, France
,
Jørgen Vestbo5 Institute of Infection, Immunity and Respiratory Medicine, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK
,
Chau Thach6 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
,
Donald Banerji6 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
,
Robert Fogel6 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
,
Francesco Patalano7 Novartis Pharma AG, Basel, Switzerland
,
Petter Olsson8 Novartis Sverige AB, Täby, Sweden
,
Konstantinos Kostikas7 Novartis Pharma AG, Basel, Switzerland
&
Jadwiga A Wedzicha9 National Heart and Lung Institute, Imperial College London, London, UK
 show all
Pages 1125-1134 | Published online: 10 Apr 2018

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Konstantinos Bartziokas, Athena Gogali & Konstantinos Kostikas. (2021) The Role of Blood Eosinophils in the Management of COPD: An Attempt to Answer the Important Clinical Questions. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:6, pages 690-699.
Read now
Claudio Micheletto, Fulvio Braido, Marco Contoli, Fabiano Di Marco & Pierachille Santus. (2019) A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2185-2193.
Read now

Articles from other publishers (10)

Michelle N. Schroeder, Hailee M. Sens & Shaina K. Shah. (2022) De-Prescribing Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: A Narrative Review. Journal of Pharmacy Practice, pages 089719002211441.
Crossref
Mario Cazzola, Clive Page, Paola Rogliani, Luigino Calzetta & Maria Gabriella Matera. (2022) Dual bronchodilation for the treatment of COPD: From bench to bedside. British Journal of Clinical Pharmacology 88:8, pages 3657-3673.
Crossref
A.L. Aguilar-Shea & C. Gallardo-Mayo. (2022) Revisión narrativa de la terapia inhalatoria en la EPOC. Medicina de Familia. SEMERGEN 48:3, pages 214-218.
Crossref
Maurizio A. CAVALLERI, Teresa DIAZ DE TERAN, Cornelius O. BARLASCINI, Paolo BANFI & Antonello NICOLINI. (2022) How to treat COPD: a critical appraisal of the FLAME Trial. Panminerva Medica 64:1.
Crossref
Bruno Sposato, Elisa Petrucci, Andrea Serafini, Fabio Lena, Leonardo Gianluca Lacerenza, Andrea Montagnani, Massimo Alessandri, Alberto Cresti, Raffaele Scala, Paola Rogliani, Alberto Ricci, Antonio Perrella & Marco Scalese. (2021) Which LABA/LAMA should be chosen in COPD patients in real life?. Pulmonary Pharmacology & Therapeutics 71, pages 102076.
Crossref
M. Zysman, B. Ribeiro Baptista, T. Soumagne, V. Marques da Silva, C. Martin, C. Thibault de Menonville, L. Boyer, B. Degano, C. Morelot Panzini, P.R. Burgel, T. Perez, A. Bourdin, C. Raherison, H. Pégliasco, D. Piperno, C. Zanetti, H. Morel, B. Delclaux, C. Delafosse, A. Lorenzo, B. Housset, F. Chabot, P. Devillier, G. Deslée & N. Roche. (2021) Optimisation du traitement médicamenteux des patients atteints de BPCO en état stable. Position de la Société de pneumologie de langue française. Actualisation 2021. Revue des Maladies Respiratoires 38:5, pages 539-561.
Crossref
Alexander G Mathioudakis, Wim Janssens, Pradeesh Sivapalan, Aran Singanayagam, Mark T Dransfield, Jens-Ulrik Stæhr Jensen & Jørgen Vestbo. (2020) Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits. Thorax 75:6, pages 520-527.
Crossref
David M.G. Halpin, Mark T. Dransfield, MeiLan K. Han, C. Elaine Jones, Sally Kilbride, Peter Lange, David A. Lipson, David A. Lomas, Fernando J. Martinez, Steve Pascoe, Dave Singh, Robert Wise & Gerard J. Criner. (2020) The effect of exacerbation history on outcomes in the IMPACT trial. European Respiratory Journal 55:5, pages 1901921.
Crossref
Lloyd Tanner & Andrew Bruce Single. (2020) Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance. Journal of Innate Immunity 12:3, pages 203-225.
Crossref
Miriam Barrecheguren & Marc Miravitlles. (2019) Treatment with inhaled α1-antitrypsin: a square peg in a round hole?. European Respiratory Journal 54:5, pages 1901894.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.